Author: Dick Benson

Cannabidiol shows sustained effects against depression for seven days

September 13, 2018

A recent study found that a single dose of cannabidiol in rats with symptoms of depression was highly effective, eliminating the symptoms on the same day and maintaining the beneficial effects for a week. The findings reinforce those of prior research showing that cannabidiol, a component of Cannabis sativa, the plant most commonly used to […]

Read More

This is how the brain forgets on purpose

September 13, 2018

Researchers from Ruhr-Universit?t Bochum and the University Hospital of Gie?en and Marburg, in collaboration with colleagues from Bonn, the Netherlands, and the UK, have analysed what happens in the brain when humans want to voluntarily forget something. They identified two areas of the brain — the prefrontal cortex and the hippocampus — whose activity patterns […]

Read More

How bad bacteria gain an edge in the gut

September 13, 2018

The bacterium?Clostridium difficile, which is responsible for the majority of antibiotic-associated diarrhea outbreaks worldwide, produces a unique compound called p-cresol to gain a competitive advantage over natural protective gut bacteria. The findings were reported by Lisa Dawson and Team at the London School of Hygiene and Tropical Medicine and colleagues on September 11 in the […]

Read More

‘Second brain’ neurons keep colon moving

September 6, 2018

Millions of neurons in the gastrointestinal tract coordinate their activity to generate the muscle contractions that propel waste through the last leg of the digestive system, according to a study of isolated mouse colons published in?JNeurosci. The newly identified neuronal firing pattern may represent an early feature preserved through the evolution of nervous systems. The […]

Read More

Cannabis extract helps reset brain function in psychosis

September 6, 2018

Research from King’s College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psychosis. Results from a new MRC-funded trial, published in?JAMA Psychiatry, provide the first evidence of how cannabidiol acts in the brain to reduce psychotic symptoms. Cannabidiol, also referred to […]

Read More

Brain function impacts how experiences contribute to depression

September 6, 2018

A study in adolescent girls reports that recent life events impact depressive symptoms differently, depending on how the brain responds to winning and losing. A strong brain response to winning boosted the beneficial impact of positive experiences on symptoms, whereas a strong response to losing enhanced the detrimental impact of negative experiences on symptoms. The […]

Read More

World’s Only Hops-Derived CBD Product

August 10, 2018

Medical Marijuana, Inc.?(OTC: MJNA), the first publicly traded cannabis company in?the United States, today announced that it has garnered global news coverage in Westword newspaper and other outlets for its partnership with Peak Health to distribute the first-ever, and only, hops (Kriya brand Humulus)-derived cannabidiol (CBD) product ImmunAg?. “We are honored to have our Real […]

Read More

World-Renowned Neurosurgeon, Health and Nutrition Expert, Dr. Joseph Maroon, Joins CV Sciences, Inc. Board of Directors

August 9, 2018

CV Sciences, Inc.?(OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) is pleased to announce the appointment of Joseph Maroon, MD, FACS (“Dr. Maroon”), to its Board of Directors. Dr. Maroon is a clinical professor and vice chairman of the Department of Neurological Surgery and the Heindl Scholar in Neuroscience at the University of Pittsburgh Medical […]

Read More

New Autoimmune Disease Is Found

August 3, 2018

Elijah Patino is a happy, healthy seven-year-old now, but it took a while to get there. For much of his life, he had a mysterious disease that made it painful to eat and painful to play. He had an uncomfortably enlarged spleen bulging in his abdomen. Something was damaging his blood cells, and he needed […]

Read More

Cannabinoids, The Heart of the Matter

August 3, 2018

GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the publication of a review article co-authored by GB Sciences and key collaborators in the Journal of the American Heart Association, which explains the potential medical benefits of using cannabinoid-based therapies for the treatment of heart diseases. GB Sciences’ own Chief Science Officer, Dr.?Andrea Small-Howard, joins […]

Read More